Asthma as an inflammatory disease

Implications for management

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Background: Eosinophilic inflammation plays a central role in the pathogenesis of asthma. Striking inflammatory changes are present in the airways of patients with all levels of disease severity. The degree of airway inflammation correlates with airway hyperresponsiveness, the primary physiologic abnormality of asthma. Inflammation is typically initiated by immunologic events (including allergy) and is driven by mediators released by various cells of the immune system, particularly eosinophils, monocytes and macrophages, lymphocytes, and mast cells. Methods: Literature on asthma and the inflammatory response was drawn from recent articles presented and reviewed in journal clubs and from selected articles from the National Library of Medicine. Results and Conclusions: The inflammatory process can be divided into six steps: triggering, signaling, migration, inflammatory cell activation, tissue damage, and resolution. Recognition of the importance of inflammation in the pathogenesis of asthma and the progression of the disease has shifted research efforts and the development of new therapeutic agents toward reduction of airway inflammation. Anti-inflammatory therapy, which can be directed against specific steps in the inflammatory process, actually reduces bronchial hyperresponsiveness. Although anti-inflammatory management has assumed a primary role in asthma therapy, short acting β2-adrenergic receptor agonists are needed for treatment of acute symptoms, and some patients require regular β2-agonist therapy despite apparently adequate anti-inflammatory therapy.

Original languageEnglish (US)
Pages (from-to)182-190
Number of pages9
JournalJournal of the American Board of Family Practice
Volume9
Issue number3
StatePublished - Nov 27 1996

Fingerprint

Disease Management
Asthma
Inflammation
Anti-Inflammatory Agents
Therapeutics
National Library of Medicine (U.S.)
Adrenergic Agonists
Eosinophils
Mast Cells
Cell Movement
Disease Progression
Monocytes
Immune System
Hypersensitivity
Macrophages
Lymphocytes
Research

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Asthma as an inflammatory disease : Implications for management. / Dolen, William K.

In: Journal of the American Board of Family Practice, Vol. 9, No. 3, 27.11.1996, p. 182-190.

Research output: Contribution to journalReview article

@article{8b315638eeed4eaf926ee7222df86ea7,
title = "Asthma as an inflammatory disease: Implications for management",
abstract = "Background: Eosinophilic inflammation plays a central role in the pathogenesis of asthma. Striking inflammatory changes are present in the airways of patients with all levels of disease severity. The degree of airway inflammation correlates with airway hyperresponsiveness, the primary physiologic abnormality of asthma. Inflammation is typically initiated by immunologic events (including allergy) and is driven by mediators released by various cells of the immune system, particularly eosinophils, monocytes and macrophages, lymphocytes, and mast cells. Methods: Literature on asthma and the inflammatory response was drawn from recent articles presented and reviewed in journal clubs and from selected articles from the National Library of Medicine. Results and Conclusions: The inflammatory process can be divided into six steps: triggering, signaling, migration, inflammatory cell activation, tissue damage, and resolution. Recognition of the importance of inflammation in the pathogenesis of asthma and the progression of the disease has shifted research efforts and the development of new therapeutic agents toward reduction of airway inflammation. Anti-inflammatory therapy, which can be directed against specific steps in the inflammatory process, actually reduces bronchial hyperresponsiveness. Although anti-inflammatory management has assumed a primary role in asthma therapy, short acting β2-adrenergic receptor agonists are needed for treatment of acute symptoms, and some patients require regular β2-agonist therapy despite apparently adequate anti-inflammatory therapy.",
author = "Dolen, {William K.}",
year = "1996",
month = "11",
day = "27",
language = "English (US)",
volume = "9",
pages = "182--190",
journal = "Journal of the American Board of Family Medicine",
issn = "1557-2625",
publisher = "American Board of Family Medicine",
number = "3",

}

TY - JOUR

T1 - Asthma as an inflammatory disease

T2 - Implications for management

AU - Dolen, William K.

PY - 1996/11/27

Y1 - 1996/11/27

N2 - Background: Eosinophilic inflammation plays a central role in the pathogenesis of asthma. Striking inflammatory changes are present in the airways of patients with all levels of disease severity. The degree of airway inflammation correlates with airway hyperresponsiveness, the primary physiologic abnormality of asthma. Inflammation is typically initiated by immunologic events (including allergy) and is driven by mediators released by various cells of the immune system, particularly eosinophils, monocytes and macrophages, lymphocytes, and mast cells. Methods: Literature on asthma and the inflammatory response was drawn from recent articles presented and reviewed in journal clubs and from selected articles from the National Library of Medicine. Results and Conclusions: The inflammatory process can be divided into six steps: triggering, signaling, migration, inflammatory cell activation, tissue damage, and resolution. Recognition of the importance of inflammation in the pathogenesis of asthma and the progression of the disease has shifted research efforts and the development of new therapeutic agents toward reduction of airway inflammation. Anti-inflammatory therapy, which can be directed against specific steps in the inflammatory process, actually reduces bronchial hyperresponsiveness. Although anti-inflammatory management has assumed a primary role in asthma therapy, short acting β2-adrenergic receptor agonists are needed for treatment of acute symptoms, and some patients require regular β2-agonist therapy despite apparently adequate anti-inflammatory therapy.

AB - Background: Eosinophilic inflammation plays a central role in the pathogenesis of asthma. Striking inflammatory changes are present in the airways of patients with all levels of disease severity. The degree of airway inflammation correlates with airway hyperresponsiveness, the primary physiologic abnormality of asthma. Inflammation is typically initiated by immunologic events (including allergy) and is driven by mediators released by various cells of the immune system, particularly eosinophils, monocytes and macrophages, lymphocytes, and mast cells. Methods: Literature on asthma and the inflammatory response was drawn from recent articles presented and reviewed in journal clubs and from selected articles from the National Library of Medicine. Results and Conclusions: The inflammatory process can be divided into six steps: triggering, signaling, migration, inflammatory cell activation, tissue damage, and resolution. Recognition of the importance of inflammation in the pathogenesis of asthma and the progression of the disease has shifted research efforts and the development of new therapeutic agents toward reduction of airway inflammation. Anti-inflammatory therapy, which can be directed against specific steps in the inflammatory process, actually reduces bronchial hyperresponsiveness. Although anti-inflammatory management has assumed a primary role in asthma therapy, short acting β2-adrenergic receptor agonists are needed for treatment of acute symptoms, and some patients require regular β2-agonist therapy despite apparently adequate anti-inflammatory therapy.

UR - http://www.scopus.com/inward/record.url?scp=0029852985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029852985&partnerID=8YFLogxK

M3 - Review article

VL - 9

SP - 182

EP - 190

JO - Journal of the American Board of Family Medicine

JF - Journal of the American Board of Family Medicine

SN - 1557-2625

IS - 3

ER -